Related references
Note: Only part of the references are listed.Emerging therapies in Parkinson disease - repurposed drugs and new approaches
Ahmad Elkouzi et al.
NATURE REVIEWS NEUROLOGY (2019)
Naturally Occurring Nervonic Acid Ester Improves Myelin Synthesis by Human Oligodendrocytes
Natalia Lewkowicz et al.
CELLS (2019)
Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
Heather Wilson et al.
LANCET NEUROLOGY (2019)
Increased anxiety-like behavior following circuit-specific catecholamine denervation in mice
Sara Ferrazzo et al.
NEUROBIOLOGY OF DISEASE (2019)
Plasma Nervonic Acid Is a Potential Biomarker for Major Depressive Disorder: A Pilot Study
Yuki Kageyama et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease
Alexandra Isabel Rosa et al.
MOLECULAR NEUROBIOLOGY (2018)
Cilostazol Mediated Nurr1 and Autophagy Enhancement: Neuroprotective Activity in Rat Rotenone PD Model
Shireen A. Hedya et al.
MOLECULAR NEUROBIOLOGY (2018)
Parkinson Disease
Houman Homayoun
ANNALS OF INTERNAL MEDICINE (2018)
Cognitive decline in Parkinson disease
Dag Aarsland et al.
NATURE REVIEWS NEUROLOGY (2017)
Non-motor features of Parkinson disease
Anthony H. V. Schapira et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Liver and kidney toxicity induced by Afzal smokeless tobacco product in Oman
Nawal Al-Mukhaini et al.
TISSUE & CELL (2017)
Age-dependent changes in nervonic acid-containing sphingolipids in mouse hippocampus
Valentina Vozella et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2017)
Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease
Qiu-shuang Zhang et al.
ACTA PHARMACOLOGICA SINICA (2017)
Xanthoceraside hollow gold nanoparticles, green pharmaceutics preparation for poorly water-soluble natural anti-AD medicine
Da-li Meng et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial
Werner Poewe et al.
LANCET NEUROLOGY (2015)
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
Benjamin Dehay et al.
LANCET NEUROLOGY (2015)
Pharmacological Treatment of Parkinson Disease A Review
Barbara S. Connolly et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Neuroimaging in Parkinson disease: from research setting to clinical practice
Marios Politis
NATURE REVIEWS NEUROLOGY (2014)
Vanadium exposure induces olfactory dysfunction in an animal model of metal neurotoxicity
Hilary Afeseh Ngwa et al.
NEUROTOXICOLOGY (2014)
Rotigotine vs ropinirole in advanced stage Parkinson's disease: A double-blind study
Yoshikuni Mizuno et al.
PARKINSONISM & RELATED DISORDERS (2014)
Bioactive barrigenol type triterpenoids from the leaves of Xanthoceras sorbifolia Bunge
Wan Xiao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Recent advances in herbal medicines treating Parkinson's disease
Xu-zhao Li et al.
FITOTERAPIA (2013)
Castration Induces Parkinson Disease Pathologies in Young Male Mice via Inducible Nitric-oxide Synthase
Saurabh Khasnavis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems
Lars Brichta et al.
TRENDS IN NEUROSCIENCES (2013)
Depression in Parkinson's disease: diagnosis and management
Javed Latoo et al.
BRITISH JOURNAL OF HOSPITAL MEDICINE (2012)
Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals
G. P. Amminger et al.
MOLECULAR PSYCHIATRY (2012)
Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease
Susan Duty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
The Aging Brain and Neurodegenerative Diseases
Gary W. Duncan
CLINICS IN GERIATRIC MEDICINE (2011)
Reduced levels of placental long chain polyunsaturated fatty acids in preterm deliveries
Madhavi V. Dhobale et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2011)
Dual motor response to L-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D-2/D-3 receptor blockade
Riccardo Viaro et al.
EXPERIMENTAL NEUROLOGY (2010)
In Vivo Characterization of a Dual Adenosine A2A/A1 Receptor Antagonist in Animal Models of Parkinson's Disease
Brian C. Shook et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
HPLC-mass spectrometry method for quantitative detection of neuroendocrine tumor markers: Vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid
Luana Lionetto et al.
CLINICA CHIMICA ACTA (2008)
Selective Activation of p38 Mitogen-Activated Protein Kinase in Dopaminergic Neurons of Substantia Nigra Leads to Nuclear Translocation of p53 in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Mice
Smitha Karunakaran et al.
JOURNAL OF NEUROSCIENCE (2008)
Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model
S. Breit et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain
F. Gagnaire et al.
ARCHIVES OF TOXICOLOGY (2006)
Comparing dopamine agonists in Parkinson's disease
U Bonuccelli
CURRENT OPINION IN NEUROLOGY (2003)
Effectiveness of the Kampo kami-shoyo-san (TJ-24) for tremor of antipsychotic-induced parkinsonism
T Ishikawa et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2000)
α-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the Parkinsonian toxin MPTP
M Vila et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
